143 related articles for article (PubMed ID: 1887860)
1. Activated T-cell subsets in benign lymphoid hyperplasias and B-cell non-Hodgkin's lymphomas.
Diaz JI; Edinger MG; Stoler MH; Tubbs RR
Am J Pathol; 1991 Sep; 139(3):503-9. PubMed ID: 1887860
[TBL] [Abstract][Full Text] [Related]
2. Host tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas.
Diaz JI; Edinger MG; Stoler M; Tubbs RR
Leuk Lymphoma; 1993 Jan; 9(1-2):85-90. PubMed ID: 8477206
[TBL] [Abstract][Full Text] [Related]
3. Low grade malignant non-Hodgkin's lymphomas and peripheral pleomorphic T-cell lymphomas in childhood--a BFM study group report.
Bucsky P; Feller AC; Reiter A; Beck J; Bertram U; Eschenbach C; Gerein V; Lakomek M; Stollmann B; Tausch W
Klin Padiatr; 1990; 202(4):258-61. PubMed ID: 2203939
[TBL] [Abstract][Full Text] [Related]
4. Immunologic markers in non-Hodgkin's lymphoma.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
[TBL] [Abstract][Full Text] [Related]
5. Cytolytic (TIA-1+) tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas. SWOG Central Repository Members.
Diaz J; Tubbs R; Stoler M; Grogan T
Leuk Lymphoma; 1993 Jan; 9(1-2):91-4. PubMed ID: 8477207
[TBL] [Abstract][Full Text] [Related]
6. CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs.
Agrawal S; Marquet J; Delfau-Larue MH; Copie-Bergman C; Jouault H; Reyes F; Bensussan A; Farcet JP
J Clin Invest; 1998 Nov; 102(9):1715-23. PubMed ID: 9802885
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.
Laane E; Tani E; Björklund E; Elmberger G; Everaus H; Skoog L; Porwit-MacDonald A
Cytometry B Clin Cytom; 2005 Mar; 64(1):34-42. PubMed ID: 15669024
[TBL] [Abstract][Full Text] [Related]
8. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia.
Lai R; Arber DA; Chang KL; Wilson CS; Weiss LM
Mod Pathol; 1998 Sep; 11(9):864-9. PubMed ID: 9758366
[TBL] [Abstract][Full Text] [Related]
9. Memory T cell subsets in B cell non-Hodgkin's lymphomas.
Diaz JI; Muro-Cacho CA; Nicely C; Edinger MG; Tubbs RR
Leuk Lymphoma; 1996 Jan; 20(3-4):291-5. PubMed ID: 8624469
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
11. [Non-Hodgkin's lymphomas of low-grade malignancy with particular reference to the lymphocytic lymphomas of B-cell origin (author's transl)].
Wessel H
Arch Geschwulstforsch; 1979; 49(8):635-47. PubMed ID: 317425
[TBL] [Abstract][Full Text] [Related]
12. Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia.
Hudnall SD; Betancourt E; Barnhart E; Patel J
Cytometry B Clin Cytom; 2008 Jan; 74(1):1-8. PubMed ID: 18061945
[TBL] [Abstract][Full Text] [Related]
13. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
[TBL] [Abstract][Full Text] [Related]
14. [Non-Hodgkin's lymphoma. Cytology and cytochemistry].
Schwarze EW
Veroff Pathol; 1986; 123():1-241. PubMed ID: 3518274
[TBL] [Abstract][Full Text] [Related]
15. [Infiltration pattern of immunocompetent lymphocytes in the tissue of malignant non-Hodgkin's lymphoma: relationship to histological and clinical parameters].
Gattringer C; Radaszkiewicz T; Greil R; Pfaller W; Huber H
Wien Klin Wochenschr; 1985 Mar; 97(5):258-63. PubMed ID: 3873140
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotype, histopathology and clinical stage: their predictive value in the prognosis of non-Hodgkin's lymphomas.
Mtasiwa DM; Imamura N; Inada T; Takimoto Y; Okada K; Nanba K; Asaoku H; Kuramoto A
Hiroshima J Med Sci; 1990 Dec; 39(4):95-102. PubMed ID: 2086567
[TBL] [Abstract][Full Text] [Related]
17. Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
Coad NA; Jones TJ; Muir KR; Parkes SE; Smith K; Raafat F; Mann JR
Pediatr Pathol Lab Med; 1997; 17(6):893-902. PubMed ID: 9353829
[TBL] [Abstract][Full Text] [Related]
18. Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course.
Lippman SM; Spier CM; Miller TP; Slymen DJ; Rybski JA; Grogan TM
Mod Pathol; 1990 May; 3(3):361-7. PubMed ID: 2194216
[TBL] [Abstract][Full Text] [Related]
19. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM
Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
[TBL] [Abstract][Full Text] [Related]
20. Expression of the CD31 antigen in normal B-cells and non Hodgkin's lymphomas.
Stacchini A; Chiarle R; Antinoro V; Demurtas A; Novero D; Palestro G
J Biol Regul Homeost Agents; 2003; 17(4):308-15. PubMed ID: 15065759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
